About vivoVerse

vivoVerse is advancing modern toxicology through integrated assay services, microfluidic technologies, and AI-enabled analysis. Our whole-organism C. elegans assays provide quantitative insights into biological responses, while our patented microfluidic platforms enable rapid, standardized imaging and high-content data collection. Combined with AI technologies for automated image analysis and phenotype measurement, vivoVerse helps researchers generate faster, more consistent, and more informative toxicity data to support better R&D decisions.